Prevalence of Developmental Venous Anomalies in Association with Sporadic Cavernous Malformations on 7T MRI

References

1. 1.↵
   1. Zabramski JM,
   2. Wascher TM,
   3. Spetzler RF, et al

   . The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 1994;80:422–32 doi:10.3171/jns.1994.80.3.0422 pmid:8113854

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Kattapong VJ,
   2. Hart BL,
   3. Davis LE

   . Familial cerebral cavernous angiomas: clinical and radiologic studies. Neurology 1995;45:492–97 doi:10.1212/wnl.45.3.492 pmid:7898703

   CrossRefPubMed
3. 3.↵
   1. Snellings DA,
   2. Girard R,
   3. Lightle R, et al

   . Developmental venous anomalies are a genetic primer for cerebral cavernous malformations. Nat Cardiovasc Res 2022;1:246–52 doi:10.1038/s44161-022-00035-7 pmid:35355835

   CrossRefPubMed
4. 4.↵
   1. Petersen TA,
   2. Morrison LA,
   3. Schrader RM, et al

   . Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype. AJNR Am J Neuroradiol 2010;31:377–82 doi:10.3174/ajnr.A1822 pmid:19833796

   Abstract/FREE Full Text
5. 5.↵
   1. de Champfleur NM,
   2. Langlois C,
   3. Ankenbrandt WJ, et al

   . Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery 2011;68:641–47; discussion 647–48 doi:10.1227/NEU.0b013e31820773cf pmid:21164377

   CrossRefPubMed
6. 6.↵
   1. Sparacia G,
   2. Speciale C,
   3. Banco A, et al

   . Accuracy of SWI sequences compared to T2*-weighted gradient echo sequences in the detection of cerebral cavernous malformations in the familial form. Neuroradiol J 2016;29:326–35 doi:10.1177/1971400916665376 pmid:27549150

   CrossRefPubMed
7. 7.↵
   1. Dammann P,
   2. Wrede K,
   3. Zhu Y, et al

   . Correlation of the venous angioarchitecture of multiple cerebral cavernous malformations with familial or sporadic disease: a susceptibility-weighted imaging study with 7-Tesla MRI. J Neurosurg 2017;126:570–77 doi:10.3171/2016.2.JNS152322 pmid:27153162

   CrossRefPubMed
8. 8.↵
   1. Dammann P,
   2. Wrede KH,
   3. Maderwald S, et al

   . The venous angioarchitecture of sporadic cerebral cavernous malformations: a susceptibility weighted imaging study at 7 T MRI. J Neurol Neurosurg Psychiatry 2013;84:194–200 doi:10.1136/jnnp-2012-302599 pmid:23085932

   Abstract/FREE Full Text
9. 9.↵
   1. Frischer JM,
   2. Göd S,
   3. Gruber A, et al

   . Susceptibility-weighted imaging at 7 T: improved diagnosis of cerebral cavernous malformations and associated developmental venous anomalies. Neuroimage Clin 2012;1:116–20 doi:10.1016/j.nicl.2012.09.005 pmid:24179744

   CrossRefPubMed
10. 10.↵
    1. Al-Shahi Salman R,
    2. Berg MJ,
    3. Morrison L, et al

    ; Angioma Alliance Scientific Advisory Board. Hemorrhage from cavernous malformations of the brain. Stroke 2008;39:3222–30 doi:10.1161/STROKEAHA.108.515544 pmid:18974380

    Abstract/FREE Full Text
11. 11.↵
    1. Perrini P,
    2. Lanzino G

    . The association of venous developmental anomalies and cavernous malformations: pathophysiological, diagnostic, and surgical considerations. Neurosurg Focus 2006;21:e5 doi:10.3171/foc.2006.21.1.6 pmid:16859258

    CrossRefPubMed
12. 12.↵
    1. Hong YJ,
    2. Chung TS,
    3. Suh SH, et al

    . The angioarchitectural factors of the cerebral developmental venous anomaly; can they be the causes of concurrent sporadic cavernous malformation? Neuroradiology 2010;52:883–91 doi:10.1007/s00234-009-0640-6 pmid:20091405

    CrossRefPubMed
13. 13.↵
    1. Sharma A,
    2. Zipfel GJ,
    3. Hildebolt C, et al

    . Hemodynamic effects of developmental venous anomalies with and without cavernous malformations. AJNR Am J Neuroradiol 2013;34:1746–51 doi:10.3174/ajnr.A3516 pmid:23598827

    Abstract/FREE Full Text
14. 14.↵
    1. Brinjikji W,
    2. El-Masri AE,
    3. Wald JT, et al

    . Prevalence of cerebral cavernous malformations associated with developmental venous anomalies increases with age. Childs Nerv Syst 2017;33:1539–43 doi:10.1007/s00381-017-3484-0 pmid:28643038

    CrossRefPubMed